Cryoxtract Instruments LLC

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website

Union Carbide is a manufacturing company based in Sudbury, MA that specializes in producing industrial chemicals and materials for various industries. With a focus on innovation and quality, Union Carbide is known for its contributions to the global supply chain and its commitment to sustainable practices. Generated from their business information

HelixBind Inc., based in Boxborough, MA, is at the forefront of revolutionizing diagnostics for bloodstream infections through its innovative platform that delivers faster, more accurate, and informative microbiology results. By enabling precise identification of invasive infections, HelixBind aims to support clinicians in developing personalized antimicrobial therapies, ultimately improving patient outcomes and combating the rise of antimicrobial resistance. Addressing the urgent challenge of sepsis—which accounts for 1.7 million cases annually in the US and over 30 million globally—HelixBind significantly reduces the turnaround time for diagnostic results. Their technology provides key insights in just four hours, compared to traditional blood cultures that take 2-3 days, allowing healthcare providers to initiate effective treatment promptly. Generated from the website